Invega 9 mg

INVEGA 9 MG is an extended-release tablet containing palperidone, used for managing certain mental health conditions. This medication is designed for oral administration and is manufactured by Janssen Inc. in Canada.

INVEGA 9 MG is primarily used for the treatment of schizophrenia and schizoaffective disorder in adults. It works by affecting the balance of natural substances in the brain. This medication is often prescribed to help manage symptoms such as hallucinations, delusions, and disorganized thinking. It is important to consult a healthcare provider to determine if INVEGA 9 MG is suitable for your specific condition.

Common effects of INVEGA 9 MG may include drowsiness, dizziness, weight gain, and restlessness. Some users may also experience nausea, constipation, or dry mouth. These effects can vary from person to person and may subside as the body adjusts to the medication. If any effects are severe or persistent, it is advisable to seek medical advice.

INVEGA 9 MG should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication may cause drowsiness, so it is advisable to avoid driving or operating heavy machinery until you know how it affects you. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

INVEGA 9 MG may interact with other medications, including those that affect the central nervous system, such as antidepressants, antipsychotics, and sedatives. It is also important to avoid alcohol while taking this medication, as it can enhance the sedative effects. Always consult your healthcare provider before starting or stopping any medication while on INVEGA 9 MG.